Among metastatic tumors from the GENIE database, the frequency of homozygous deletions at EPCAM (21.4% vs. 0%, Bonferroni-adjusted p = 4.2 × 10−16) was significantly higher in MMR-d tumors (Figure 5b, Supplementary Table S7). This evidence concerns the gene EPCAM and metastatic neoplasm.